Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05459402 · ClinicalTrials.gov registry record · Phase 2
Divided or Single Exposure (DOSE) Study
A Phase 2 study of Chronic Pain and Opioid Use Disorder, sponsored by University of Maryland, Baltimore.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05459402 is a Phase 2 study of Chronic Pain and Opioid Use Disorder that is actively recruiting participants, run by University of Maryland, Baltimore. The registered enrollment target is 150 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05459402, a Phase 2 study of Chronic Pain and Opioid Use Disorder, is actively recruiting participants, sponsored by University of Maryland, Baltimore.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.
Conditions Studied
Interventions
- DRUG Methadone (100% dose)
- DRUG Methadone (50% dose)
Study Locations (1)
Maryland
- Addiction Treatment Services (ATS) - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-02-21 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05459402
The ClinicalTrials.gov registry entry for NCT05459402 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (81% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Methadone (100% dose) is the first listed.
NCT05459402 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05459402 about?
NCT05459402 is a clinical study titled "Divided or Single Exposure (DOSE) Study". This study will evaluate whether once versus twice daily dosing of methadone will be an effective method for managing comorbid pain and opioid use disorder.
What is the current status of trial NCT05459402?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2023-02-21. Estimated completion is 2028-06-01.
What conditions does trial NCT05459402 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder, Methadone.
What interventions are being tested in trial NCT05459402?
The interventions under investigation include: Methadone (100% dose) (DRUG), Methadone (50% dose) (DRUG).
Who is sponsoring clinical trial NCT05459402?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05459402 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PAIN: a Project Assessing the Impact of a Novel Cannabinoid Product
RECRUITING · Phase 2
-
The Role of Brain Dopamine in Chronic Pain
RECRUITING · Phase 2
-
Generate and Test the Reliability of a PD Model of OXT on Pupillary Hippus as a Measure of CNS Activity
RECRUITING · Phase 2
-
A Mobile Intervention to Reduce Pain and Improve Health-III
RECRUITING · Phase 2
-
Dronabinol as an Adjunct for Reducing Pain
RECRUITING · Phase 2
-
Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.